VRTX436.95-2.99%
VRTX · US
1y range: 423.24 → 499.17 · as of 2026-05-15
Next earnings
2026-08-03
in 76d
Recent material news
- Halozyme Q1 Beat Driven by Royalty Outperformance, Strong Demand, Morgan Stanley2026-05-12T15:54
- Barclays Maintains Overweight on Vertex Pharmaceuticals, Raises Price Target to $6152026-05-06T11:43
- VRTX's Q1 Earnings Beat Estimates, New Products Aid Sales Growth2026-05-05T16:57
- These Analysts Revise Their Forecasts On Vertex Pharmaceuticals After Q1 Earnings2026-05-05T14:15
- Morgan Stanley Maintains Overweight on Vertex Pharmaceuticals, Raises Price Target to $6162026-05-05T13:52
- Bernstein Maintains Outperform on Vertex Pharmaceuticals, Lowers Price Target to $5722026-05-05T13:03
- CRISPR Therapeutics' Q1 Loss Wider Than Expected, Sales Miss Estimates2026-05-05T12:19
- RBC Capital Maintains Outperform on Vertex Pharmaceuticals, Raises Price Target to $5432026-05-05T11:54
Want this depth on every stock you watch?
ThickerPeek writes a daily AI digest on 165+ stocks, weekly theses, earnings briefings, and alerts — for €19/mo. Free tier available.
Not investment advice. ThickerPeek is a research tool. AI-written content is informational, not a buy/sell recommendation. Investment decisions are your own responsibility.